Herren Wu is Senior Vice President and Head of Antibody Discovery and Protein Engineering (ADPE), R&D at AstraZeneca.体育外围app下载

Herren founded the Department of Antibody Discovery and Protein Engineering in January 2002. During his tenure, Herren has successfully integrated ADPE platforms across R&D. Under his leadership, ADPE has developed many proprietary cutting-edge technology platforms, including half-life extension technology (YTE), bi-specifics/multi-specifics, protein scaffolds, antibody-drug conjugates, Blood-Brain-Barrier technology, peptide therapeutics, phenotypic screening and most recently mass-spec proteomics and non-natural amino acid technology.

In 2006, Herren received the Senior Technology Fellow Emerald Honors award. He is also an inventor on 43 granted patents and 50 patent applications related to antibody/protein therapeutics and technologies. This is in addition to 更多 than 60 manuscript publications.

Herren received his bachelor’s degree in Chemistry from the National Taiwan University and his doctorate in Molecular and Cellular Biology from the University of Massachusetts, Amherst. He completed his postdoctoral training at The Scripps Research Institute in La Jolla, California.

Through our work extending the half-life of antibodies, we overcame the challenges and put the antibody to the test in human clinical trials and it worked. It's like a Eureka! moment. Not many people can have that type of experience.

Herren Wu Senior Vice President and Head of Antibody Discovery and Protein Engineering (ADPE), R&D
足球赛外围投注平台

体育外围app下载

体育外围app下载

足球外围网

体育外围app下载

体育外围app下载

外围体育

体育外围app下载

体育外围app下载

体育外围app下载

LATEST PROJECT

外围投注app

LEADERSHIP

外围投注app

STRATEGY

外围投注app

NON-MAB TECHNOLOGIES

外围投注app

外围投注app

Oligospecific antibodies for simultaneous targeting体育外围app下载

Dimasi N, Gao C, Fleming R et al. The design and characterization of oligospecific antibodies for simultaneous targeting of multiple disease mediators. Mol. Biol. 2009. 393(3):672-92

IgG1 enhanced binding to FcRn 体育外围app下载

Dall'Acqua WF, Kiener PA, Wu H. J. Properties of human IgG1s engineered for enhanced binding to FcRn. Biol. Chem. 2006: 281(33):23514-24

Building zinc fingers体育外围app下载

Wu H, Yang WP, Barbas CF 3rd. Building zinc fingers by selection: towards a therapeutic application. Proc. Natl. Acad. Sci. USA.1995; 92(2):344-8.

外围投注app

and help us deliver life-changing medicines 

Be among our employees who continue to make us an innovation-driven company that stands firmly among the world’s leaders in biopharmaceuticals.